Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

G PellacaniT SchlesingerN BhatiaBrian BermanM LebwohlJ L CohenG K PatelR KunstfeldI HadshiewJ T Lear

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

This article provides an overview of presentations and symposium discussions, summarizing key phase-III results and real-life clinical experience with tirbanibulin shared by dermatologists across Europe.

Keyphrases

phase iii
clinical practice
open label
clinical trial
double blind
phase ii
placebo controlled
electronic health record
big data
randomized controlled trial
data analysis